Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease

Burger, PM; Dorresteijn, JAN; Fiolet, ATL; Koudstaal, S; Eikelboom, JW; Nidorf, SM; Thompson, PL; Cornel, JH; Budgeon, CA; Westendorp, ICD; Beelen, DPW; Martens, FMAC; Steg, PG; Asselbergs, FW; Cramer, MJ; Teraa, M; Bhatt, DL; Visseren, FLJ; Mosterd, A

Mosterd, A (通讯作者),Dutch Cardiovasc Res Network WCN, Moreelsepk 1, NL-3511 EP Utrecht, Netherlands.;Mosterd, A (通讯作者),Meander Med Ctr, Dept Cardiol, Maatweg 3, NL-3813 TZ Amersfoort, Netherlands.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023; 30 (18): 1950

Abstract

Lay Summary The long-term benefits of treatment with low-dose colchicine were estimated for 36 642 individuals with coronary heart disease, and compar......

Full Text Link